Life Science Software

Global Market Trajectory & Analytics

MCP13014

EXECUTIVE ENGAGEMENTS

POOL

19853
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1986
Interactions with Platform & by Email

PARTICIPANTS

397
Unique # Participated

VALIDATIONS

81
Responses Validated*

COMPANIES

14
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2022

TABLES

123

PAGES

182

EDITION

8

PRICE

USD 4950

CODE

MCP13014


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

S M N T

%

VALIDATED RESEARCH *

S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T

* S = Strong; M = Moderate; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
  

HIGHLIGHTS & REPORT INDEX

Global Life Science Software Market to Reach $8.1 Billion by 2026

Amid the COVID-19 crisis, the global market for Life Science Software estimated at US$5.5 Billion in the year 2020, is projected to reach a revised size of US$8.1 Billion by 2026, growing at a CAGR of 6.6% over the analysis period. Cloud-based, one of the segments analyzed in the report, is projected to record a 6.8% CAGR and reach US$5.3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the On-Premise segment is readjusted to a revised 6.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.8 Billion in 2021, While China is Forecast to Reach $1.4 Billion by 2026

The Life Science Software market in the U.S. is estimated at US$1.8 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2026 trailing a CAGR of 6.2% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

SELECT PLAYERS

ArisGlobal LLC; Ducen IT; DXC Technology; EPAM Systems, Inc.; Fujitsu Ltd.; GE Healthcare; HCL Technologies Ltd.; Instem Group of Companies; Medidata Solutions, Inc.; Oracle Corporation; PDS; SAP SE; SAS Institute, Inc.; Signiant, Inc.; Veeva Systems, Inc.; Xybion Corporation

SEGMENTS

» End-Use (Pharmaceutical, Biotechnology, Other End-Uses) » Segment (Cloud-based, On-Premise)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Life Science Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Life Science Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Life Science Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Cloud-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Cloud-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cloud-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
Active Players in United States
USA Current & Future Analysis for Life Science Software by Segment - Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Life Science Software by Segment - Cloud-based and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Life Science Software by Segment - Percentage Breakdown of Value Sales for Cloud-based and On-Premise for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2012, 2020 & 2027
CANADA
Active Players in Canada
Canada Current & Future Analysis for Life Science Software by Segment - Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Life Science Software by Segment - Cloud-based and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Life Science Software by Segment - Percentage Breakdown of Value Sales for Cloud-based and On-Premise for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2012, 2020 & 2027
JAPAN
Active Players in Japan
Japan Current & Future Analysis for Life Science Software by Segment - Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Life Science Software by Segment - Cloud-based and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Life Science Software by Segment - Percentage Breakdown of Value Sales for Cloud-based and On-Premise for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2012, 2020 & 2027
CHINA
Active Players in China
China Current & Future Analysis for Life Science Software by Segment - Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Life Science Software by Segment - Cloud-based and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Life Science Software by Segment - Percentage Breakdown of Value Sales for Cloud-based and On-Premise for the Years 2012, 2020 & 2027
China Current & Future Analysis for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Life Science Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Life Science Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Life Science Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Life Science Software by Segment - Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Life Science Software by Segment - Cloud-based and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Life Science Software by Segment - Percentage Breakdown of Value Sales for Cloud-based and On-Premise for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2012, 2020 & 2027
FRANCE
Active Players in France
France Current & Future Analysis for Life Science Software by Segment - Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Life Science Software by Segment - Cloud-based and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Life Science Software by Segment - Percentage Breakdown of Value Sales for Cloud-based and On-Premise for the Years 2012, 2020 & 2027
France Current & Future Analysis for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2012, 2020 & 2027
GERMANY
Active Players in Germany
Germany Current & Future Analysis for Life Science Software by Segment - Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Life Science Software by Segment - Cloud-based and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Life Science Software by Segment - Percentage Breakdown of Value Sales for Cloud-based and On-Premise for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2012, 2020 & 2027
ITALY
Active Players in Italy
Italy Current & Future Analysis for Life Science Software by Segment - Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Life Science Software by Segment - Cloud-based and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Life Science Software by Segment - Percentage Breakdown of Value Sales for Cloud-based and On-Premise for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2012, 2020 & 2027
UNITED KINGDOM
Active Players in United Kingdom
UK Current & Future Analysis for Life Science Software by Segment - Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Life Science Software by Segment - Cloud-based and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Life Science Software by Segment - Percentage Breakdown of Value Sales for Cloud-based and On-Premise for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2012, 2020 & 2027
REST OF EUROPE
Active Players in Rest of Europe
Rest of Europe Current & Future Analysis for Life Science Software by Segment - Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Life Science Software by Segment - Cloud-based and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Life Science Software by Segment - Percentage Breakdown of Value Sales for Cloud-based and On-Premise for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Active Players in Asia-Pacific
Asia-Pacific Current & Future Analysis for Life Science Software by Segment - Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Life Science Software by Segment - Cloud-based and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Life Science Software by Segment - Percentage Breakdown of Value Sales for Cloud-based and On-Premise for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2012, 2020 & 2027
REST OF WORLD
Active Players in Rest of World
Rest of World Current & Future Analysis for Life Science Software by Segment - Cloud-based and On-Premise - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Life Science Software by Segment - Cloud-based and On-Premise Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Life Science Software by Segment - Percentage Breakdown of Value Sales for Cloud-based and On-Premise for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Life Science Software by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Life Science Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2012, 2020 & 2027
Total Companies Profiled: 14

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com